PSYCHEMEDICS CORP
10-Q, EX-27, 2000-11-09
MEDICAL LABORATORIES
Previous: PSYCHEMEDICS CORP, 10-Q, 2000-11-09
Next: AUDIOVOX CORP, 8-K, 2000-11-09



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       2,486,845
<SECURITIES>                                   861,957
<RECEIVABLES>                                4,405,889
<ALLOWANCES>                                   448,066
<INVENTORY>                                    421,173
<CURRENT-ASSETS>                             8,687,372
<PP&E>                                       9,224,591
<DEPRECIATION>                               6,080,459
<TOTAL-ASSETS>                              12,173,513
<CURRENT-LIABILITIES>                        2,390,187
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       113,062
<OTHER-SE>                                   9,502,744
<TOTAL-LIABILITY-AND-EQUITY>                12,173,513
<SALES>                                     15,176,165
<TOTAL-REVENUES>                            15,176,165
<CGS>                                        6,767,195
<TOTAL-COSTS>                                6,767,195
<OTHER-EXPENSES>                             5,945,008
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              2,864,037
<INCOME-TAX>                                 1,180,900
<INCOME-CONTINUING>                          1,683,137
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,683,137
<EPS-BASIC>                                       0.08
<EPS-DILUTED>                                     0.08


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission